DigiPath

About:

DigiPath, Inc. (OTC: DIGP) has over 60 years combined expertise in pioneering digital pathology

Website: http://www.digipath.com

Twitter/X: digipathlabs

Top Investors: Growth Capital Fund

Description:

DigiPath, Inc. (OTC: DIGP) has over 60 years combined expertise in pioneering digital pathology, installing solutions at over 750 academic medical centers, reference laboratories, biopharmaceutical organizations, and life science research institutions worldwide. The company aims to become a leader in botanical nutraceutical research and testing by ensuring product safety, as well as providing trademarking and licensing services to protect intellectual property. In addition, the company also intends to provide professional industry training – both online and in person – to prepare new professionals for new opportunities in the botanical and nutraceutical industries.